EXCERPT GOTHENBURG, Sweden, Aug. 13, 2020 /PRNewswire/ — Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) today announced that it entered into a license agreement with Solasia Pharma K.K […]

EXCERPT Slough, UK and Richmond, VA, May 9, 2019 – Indivior PLC (LON: INDV) (“Indivior” or the “Group”) today announced that it has entered into a definitive license agreement with […]

EXCERPT TOKYO and TORONTO, July 31, 2018 (GLOBE NEWSWIRE) — Vasomune Therapeutics (“Vasomune”), a Toronto-based spin-out from Sunnybrook Research Institute and MaRS Innovation, and AnGes, Inc. (Tokyo, TYO:4563), a Japan-based […]

EXCERPT TORONTO, CANADA, BEDMINSTER, N.J., and DUBLIN, IRELAND–(Marketwired – Sept. 25, 2017) – HLS Therapeutics Inc. (“HLS”) and Amarin Corporation plc (“Amarin”) announced today an exclusive agreement between the parties […]

EXCERPT LONDON and PHILADELPHIA and CAMBRIDGE, England, July 20, 2017 /PRNewswire/ — AMO Pharma Limited (“AMO Pharma”), a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options, today announced it has entered […]

EXCERPT – Company plans to build on existing Canadian and U.S. Clozaril® franchise and Canadian breadth of services to physicians and patients TORONTO and MONTREAL, Sept. 9, 2015 /CNW/ – HLS Therapeutics Inc. (“HLS” or […]